West Financial Advisors’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

West Financial Advisors’s Portfolio LUMO Stock Details LUMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-784	Closed	-$3.04K	–	226
2024 Q3	$3.04K	Hold	784	–	–	﹤0.01%	166
2024 Q2	$1.82K	Hold	784	–	–	﹤0.01%	142
2024 Q1	$2.21K	Hold	784	–	–	﹤0.01%	134
2023 Q4	$2.49K	Hold	784	–	–	﹤0.01%	139
2023 Q3	$2.59K	Hold	784	–	–	﹤0.01%	169
2023 Q2	$2.59K	Hold	784	–	–	﹤0.01%	148
2023 Q1	$2.6K	Hold	784	–	–	﹤0.01%	135
2022 Q4	$2.83K	Hold	784	–	–	﹤0.01%	131
2022 Q3	$7K	Hold	784	–	–	﹤0.01%	148
2022 Q2	$6K	Hold	784	–	–	﹤0.01%	137
2022 Q1	$7K	Hold	784	–	–	﹤0.01%	158
2021 Q4	$5K	Hold	784	–	–	﹤0.01%	159
2021 Q3	$7K	Hold	784	–	–	﹤0.01%	131
2021 Q2	$8K	Hold	784	–	–	﹤0.01%	126
2021 Q1	$9K	Hold	784	–	–	﹤0.01%	126
2020 Q4	$28K	Buy	+784	New	+$13.5K	0.01%	101

West Financial Advisors's LUMO Position: Q4 2024 in Review

West Financial Advisors sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q4 2024, closing a stake of 784 shares — an estimated $3.04K sold.

West Financial Advisors first reported a position in LUMO in Q4 2020 and held it in 16 quarters. The position peaked at $28K in Q4 2020. 0 funds tracked by Wall St. Rank hold LUMO as of Q4 2024.

West Financial Advisors reported no remaining Lumos Pharma, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
West Financial Advisors sold 784 Lumos Pharma, Inc. Common Stock shares in Q4 2024, an estimated $3.04K.
West Financial Advisors first reported a position in Lumos Pharma, Inc. Common Stock in Q4 2020 and held it in 16 quarters.
West Financial Advisors's Lumos Pharma, Inc. Common Stock position peaked at $28K in Q4 2020.
0 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q4 2024.

Based on West Financial Advisors's 13F filing for Q4 2024, filed 14 Jan 2025.